[Therapy of pulmonary tuberculosis].
D000818:Animals; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D004351:Drug Resistance; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D051379:Mice; D011013:Pneumonectomy; D012293:Rifampin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000995:Antitubercular Agents; D012293:Rifampin
Therapie der Lungentuberkulose.